JPRN-UMIN000052832招募中Unknown
Study on the usefulness of fecal calprotectin by gold colloid agglutination in ulcerative colitis and the relevance of other biomarkers - UC-CAL Study
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Persons who are unable to give their consent. Persons who cannot understand the explanation. Persons who are judged to be unable to undergo colonoscopy due to their general condition. Persons whose prothrombin time is less than 50% or platelet count is less than 50,000/microl in the blood test. Persons deemed unsuitable by the principal investigator.
研究者
相似试验
已完成
不适用
Relevance of fecal calprotectin as a biomarker to predict the outcome of Adalimumab therapy in Ulcerative Colitis patients.lcerative ColitisJPRN-UMIN000022104Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine54
进行中（未招募）
不适用
Does measurement of fecal calprotectin levels help distinguish various colitis?Diseases of the digestive systemKCT0003598Eulji University Hospital30
已完成
不适用
The value of faecal calprotectin (CPT) in monitoring the response to treatment of patients with inflammatory bowel diseaseInflammatory bowel diseaseDigestive SystemCrohn's disease [regional enteritis]ISRCTN81965907Department of Health (UK)80
招募中
不适用
The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors’- a pilot studycolitisNL-OMON25248KI-AV50
招募中
不适用
*The use of fecal calprotectin in detecting immunotherapy induced colitis and feasibility for the use of immunohistochemical markers in patients receiving checkpoint inhibitors*- a pilot study10017966colitisNL-OMON42995ederlands Kanker Instituut50